Dr. Syed Qaiser Shah
  • Professor

Dr. Syed Qaiser Shah

Ph.D , University of Peshawar (2007) in Biochemistry
Research Interest:  Nuclear Medicine, Biochemistry
Telephone: 03339254009
Resume: [ Download ]

Experience

  • Associate Professor, Institute of Chemical Sciences, University of Peshawar , Peshawar, Pakistan (Full Time November 02, 2013 till date )
  • Director Undergraduate Studies University of Peshawar , Peshawar, Pakistan (September 11, 2018 till date )
  • Assistant Professor, Center for Nuclear and Molecular Studies, Nuclear Medicine Research Laboratory, University of Peshawar, Peshawar, Pakistan (Full Time April 30, 2012 – November 01, 2013)
  • Assistant Director NMRL,  University of Peshawar , NWFP, Pakistan (Full Time June 06,2009 – April 29, 2012)
  • Assistant Professor (TTS), Department of Chemistry University of Malakand, NWFP, Pakistan  (Full Time February 25, 2009 – June 05, 2009)
  • Assistant Director NMRL,  Center for Nuclear and Molecular Studies, Nuclear Medicine Research Laboratory, University of Peshawar University of Peshawar , NWFP, Pakistan (Full Time June 26, 2006 –February 24, 2009 )
  • Project Coordinator and Focal Person HRD (HEC)( Additional February 01, 2005- May  03, 2008).
  • Assistant Registrar (P&D), University of Peshawar, NWFP, Pakistan (Full Time February 01, 2005- June 26, 2006)
  • Deputy Director Planning, Kohat University of Science & Technology KOHAT, NWFP, Pakistan (Full Time from December 01, 2004- January 31, 2005).
  • Assistant Controller of Examinations, Kohat University of Science & Technology KOHAT, NWFP, Pakistan (Full Time from August 18, 2003 to December 01, 2004).
  • Consultant (P&D), Kohat University of Science & Technology KOHAT, NWFP, Pakistan (Additional from August 18, 2003 to December 01, 2004).
  • Focal Person HRD, University of Peshawar, NWFP, Pakistan (From 17, October 2006 to 03 May 2008).

 PUBLICATIONS

  1. Shah SQ, Khan AU, Khan MR (2010) Synthesis, biodistribution and evaluation of 99mTc-sitafloxacin kit: A novel infection imaging agent. J Radioanal Nucl Chem 284: 189 –  193.
  2. Shah SQ, Khan AU, Khan MR (2010) Radiosynthesis and biodistribution of 99mTc-rifampicin: A novel radiotracer for in-vivo infection imaging. Appl Radiat Isot. 68 : 2255 – 2260.
  3. Shah SQ, Khan AU, Khan MR (2011) Radiosynthesis of 99mTc-nitrifuratonin a novel radiotracer for in vivo imaging of Escherichia coli infection. J Radioanal Nucl Chem. 287:417 – 422.
  4. Shah SQ, Khan AU, Khan MR (2011) 99mTc-novobiocin: A novel radiotracer for infection imaging. Radiochimica acta. 99 : 53 –58.
  5. Shah SQ, Khan AU, Khan MR (2010) Radiosynthesis, biodistribution and scintigraphy of the 99mTc-Teicoplanin complex in artificially infected animal models. J Label Compd Radiopharm. 54: 145 – 149.
  6. Shah SQ, Khan AU, Khan MR (2011) Radiosynthesis and biological evaluation of 99mTcN-sitafloxacin dithiocarbamate as a potential radiotracer for Staphylococcus aureus infection. J Radioanal Nucl Chem. 287: 827 – 832.
  7. Shah SQ, Khan AU, Khan MR (2011) Radiosynthesis and biodistribution of 99mTcN-Garenoxacin dithiocarbamate complex a potential infection imaging agent. J Radioanal Nucl Chem.288: 59 – 64.
  8. Shah SQ, Khan AU, Khan MR (2011) Radiosynthesis and biological evolution of 99mTc(CO)3-sitafloxacin dithiocarbamate complex: A promising Staphylococcus aureus infection radiotracer. J Radioanal Nucl Chem. 288: 131 – 136.
  9. Shah SQ, Khan AU, Khan MR (2011) 99mTc (CO)3-Garenoxacin dithiocarbamate synthesis and biological evolution in rats infected with multiresistant Staphylococcus aureus and penicillin-resistant Streptococci.. J Radioanal Nucl Chem. 288: 171 – 176.
  10. Shah SQ, Khan AU, Khan MR (2011) Synthesis, biological evaluation and biodistribution of the 99mTc- Garenoxacin complex in artificially infected rats.  J Radioanal Nucl Chem.288: 207 – 213.
  11. Shah SQ & Khan MR (2011) Radiocomplexation and biological characterization of the 99mTcN-trovafloxacin dithiocarbamate: A novel methicillin-resistant Staphylococcus aureus infection imaging agent. J Radioanal Nucl Chem. 288: 215 – 220.
  12. Shah SQ & Khan MR (2011) Synthesis of the 99mTc(CO)3- trovafloxacin dithiocarbamate  complex and biological evaluation in artificially methicillin-resistant Staphylococcus aureus infected rats model.  J Radioanal Nucl Chem. 288: 297 – 302.
  13. Shah SQ & Khan MR (2011) Radiolabeling of gemifloxacin with technetium-99m and biological evaluation in artificially Streptococcus pneumoniae infected rats J Radioanal Nucl Chem. 288: 307 – 312.
  14. Shah SQ & Khan MR (2011) Evaluation of 99mTcN-moxifloxacin dithiocarbamate, as a potential radiopharmaceutical for scintigraphic localization of infectious foci. J Radioanal Nucl Chem. 288: 357 – 362.
  15. Shah SQ & Khan MR (2011) Radiocharacterization of the 99mTc-rufloxacin complex and biological evaluation in Staphylococcus aureus infected rat model. J Radioanal Nucl Chem. 288: 373 –378.  
  16. Shah SQ & Khan MR (2011) Radiosynthesis and biodistribution of 99mTc-tricarbonyl temafloxacin dithiocarbamate complex: A potential Streptococci pneumoniae infection radiotracer J Radioanal Nucl Chem. 288: 411 – 416.
  17. Shah SQ & Khan MR (2011) Synthesis of techentium-99m labeled clinafloxacin (99mTc-CNN) complex and biological evaluation as a potential Staphylococcus aureus infection imaging agent. J Radioanal Nucl Chem. 288: 423 – 428.   
  18. Shah SQ, Khan AU, Khan MR (2011) Radiosynthesis and biological evaluation of 99mTcN-sitafloxacin dithiocarbamate as a potential radiotracer for Staphylococcus aureus infection. J Radioanal Nucl Chem. 287: 827 – 832.
  19. Shah SQ & Khan MR (2011) 99mTc(CO)3-tosufloxacin  dithiocarbamate  complexation and radiobiological evaluation in male Wister rat model. J Radioanal Nucl Chem. 288: 485 – 490.
  20. Shah SQ &Khan MR (2011) Synthesis of 99mTcV≡N-Pazufloxacin dithiocarbamate complex and biological evaluation in Wister rats artificially infected with Escherichia coli. J Radioanal Nucl Chem. 288: 511– 516.    
  21. Shah SQ & Khan MR (2011) Radiosynthesis and biological evaluation of the 99mTc-tricarbonyl moxifloxacin dithiocarbamate complex as a potential Staphylococcus aureus infection radiotracer. Appl Radiat Isot. 69: 686 – 690.
  22. Shah SQ, Khan AU, Khan MR (2011) Radiosynthesis and biological evaluation of 99mTc-Prulifloxacin in artificially infected animals. Nuklearmedizin. 50: 134-140.
  23. Shah SQ & Khan MR (2011) Radiosynthesis and biodistribution of the 99mTc-travofloxacin complex as a potential methicillin resistant staphylococcus aureus infection radiotracer. J Radioanal Nucl Chem. 288: 525 – 530.   
  24. Shah SQ & Khan MR (2011) Radiosynthesis and characterization of the 99mTc-fleroxacin (99mTc-FXN) complex: A novel Escherichia coli infection imaging agent. Transition Metal Chemistry. 36: 283 – 287.
  25.  Shah SQ & Khan MR (2011) 99mTcN-gatifloxacin dithiocarbamate complex: a novel multi-drug-resistance Streptococcus pneumoniae (MRSP) infection radiotracer. J Radioanal Nucl Chem.  289: 903 – 908.
  26. Shah SQ & Khan MR (2012) Synthesis of 99mTc(CO)3-pazufloxacin dithiocarbamate complex and biodistribution  in experimentally Escherichia coli induced infection in female nude mice.  Synthesis and Reactivity in Inorganic, Metal-Organic, and Nano-Metal Chemistry. 42: 190 – 195.
  27. Shah SQ & Khan MR (2012) Synthesis, biological evaluation and biodistribution of technetium-99m (99mTc) labeled dithiocarbamate derivative of novobiocin as a potential infection radiotracer. Radiochemistry. 54: 279 – 283.
  28. Shah SQ & Khan MR (2011) Radiosynthesis of 99mTc(CO)3-Clinafloxacin dithiocarbamate and its biological evaluation as a potential Staphylococcus auras infection radiotracer.  Nuclear Medicine and Molecular Imaging. 45: 248 – 254.
  29. Shah SQ & Khan AU, Khan MR (2012) 99mTc(CO)­3- Ibritumomab tiuxetan; a novel Radioimmunoimaging (RII) agent of B cell non-Hodgkin's lymphoma (NHL). Biological Chemistry. 393: 71 – 75.
  30. Alamzeb M, Khan MR, Ali S, Shah SQ (2013) Antimicrobial properties of extracts and compounds isolated from Berberis jaeschkeana. Bangladesh Journal of Pharmacology. 8: 107– 109.
  31. Ghias Uddin, Abdur Rauf, Bina Shaheen Siddiqui and Syed Qaiser Shah (2011) Preliminary Comparative Phytochemical Screening of Diospyros lotus Stewart. Middle-East Journal of Scientific Research 10: 78-81.
  32. Ali S, Igoli J, Clements C, Semaan D, Alamzeb M, Rashid M, Shah SQ, Ferro V, Gray AI , Khan MR (2013) Antidiabetic and antimicrobial activities of fractions and compounds isolated from Berberis brevissima Jafri and Berberis parkeriana Schneid. Bangladesh Journal of Pharmacology. 8: 336– 342.
  33.  Uddin G, Ullah W, Siddiqui BS, Shah SQ (2013) Grewialin and optivanin new constituents from the stem bark of Grewia optiva Drummond ex Burret (Tiliaceae). Natural Product Research. 27: 215– 220.
  34. Naqvi SA, Khan ZA, Nagra SA, Yar M, Sherazi TA, Shahzad SS, Shah SQ, Mahmood N, Ishfaq MM, Mather SJ (2013) Novel indium-111 labeled gastrin peptide analogues (MG-CL1-4): Synthesis and quality control Pak J Pharm Sci.  26:299-305.
  35. Shah SQ &Khan MR (2013) Synthesis of 99mTc Labelled Temafloxacin Complex and Biodistribution in Male Wistar Rats Artificially Infected with Streptococci pneumonia. Advances in Clinical and Experimental Medicine. 22:319-325.
  36. Shah SQ & Khan MR. (2013) Synthesis and Biological Evaluation of the 99mtcn-Gemifloxacin Dithiocarbamate Complex: A Novel Streptococcus Pneumoniae Infection  imaging agent. Journal of Molecular Imaging and Dynamics. 110: 1-4.
  37. Mamoon-Ur-Rashid, Ali S, Alamzeb M, Igoli J, Clements C,  Shah SQ, Ferro VA, Gray AI, Khan MR. (2014) Phytochemical and antitrypanosomal investigation of the fractions and compounds isolated from Artemisia elegantissima. Pharmaceutical Biology. 52: 983-987.
  38. Shah SQ &  Khan MR (2014) Synthesis of 99mTcN-clinafloxacin Dithiocarbamate Complex and Comparative Radiobiological Evaluation in Staphylococcus aureus Infected Mice. World Journal of Nuclear Medicine. 13: 154-158.
  39. Khan AU, Irfanullah J, Shah SQ, Fatima S (2015) 99mTc-phytate trans-splenic portal scintigraphy in the diagnosis of cirrhotic portal hypertension and compensatory circulation. Abdominal Imaging. 40: 258-264.
  40. Ullah H, Shah SQ et al (2019) In-house preparation of pentavalent 99mTc labeled dimercaptosuccinic acid [99mTc(V)DMSA], its quality control and clinical applications. 8: 1-7.
  41. Shah SQ & Khattak S (2015) Synthesis, Characterization, Biodistribution and Scintigraphic Evaluation of Technetium-99m (99mTc) labelled Pazufloxacin. Nuclear Medicine & Radiation Therapy. S8: 1-6.
  42. Shah SQ & Alam M (2017). Synthesis of 99mTc-Rifabutin: A Potential Tuberculosis Radiodiagnostic Agent. Infectious Disorders –Drug Targets. 17:185-191
  43. Shah SQ & Momin S (2017) Synthesis of Labeled Rifabutin dithiocarbamate: A potential Mycobacterium Tuberculosis Imaging agent. Journal of Glycomics and Metabolism.1:12-22.
  44. Shah SQ & Mahmood S (2018) Evaluation of 99mTc-Labeled Bevacizumab–N-HYNIC Conjugate in Human Ovarian Tumor Xenografts. Cancer Biotherapy and Radiopharmaceuticals. 33: 96-102.
  45. Shah SQ & Raana G (2018)  Imaging Prostate Cancer (PCa) with [99mTc(CO)3]Finasteride Dithiocarbamate. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS. 61:550-556.
  46.  Shah SQ & Raana G (2019) Synthesis and preclinical investigation of 99mTc-p-SCN-Bzl-DTPAcetuximab for targeting EGFR using head and neck squamous cell carcinoma (HNSCC) xenografts. Molecular Biology Reports (2019) 46:1675–1682
  47. Shah SQ &Ullah N (2019) Preclinical Evaluation of 99mTc-Ethambutol,  an Alternative Tuberculosis Diagnostic Tool. Radiochemistry. 61:233-237.
  48. Raana G & Shah SQ, (2019)

Research Grants

  1. Radiosynthesis, characterization, biodistribution and scintigraphic evaluation of 99mTc(CO)3~Cetuximab: a novel radioimunodiagnostic agent of the tumor over expressing Epidermal Growth Factor Receptor (EGFR) capital cost 2,775,555/= in PKR (COMPLETED).  
  2. Establishment of Nuclear Medicine Research Laboratory phase I & II embedded   through DDWP/HEC capital cost 17.00 million in PKR (COMPLETED)

M.Phil  produced

  1. Shahia Khattak (M.Phil) Synthesis, Characterization, Biodistribution and Scintigraphic Evaluation of the Technetium-99m Labeled Pazufloxacin: A NOVEL Infection Radiotracer
  2. Mamoona Alam (M.Phil) Synthesis 99mTc -Rifapentine: A NOVEL tuberculosis radiodiagnostic agent
  3. Saima Momin (M.Phil) RADIOSYNTHESIS OF 99mTc(CO)3-RIFABUTIN DITHIOCARBAMATE: A POTENTIAL MYCOBACTERIUM TUBERCULOSIS IMAGING AGENT
  4. Hameed Ullah (M.Phil)  SYNTHESIS AND RADIOBIOLOGICAL EVALUATION OF 188RE-TIN COLLOID: A POTENTIAL INTRA-CAVITORY RADIOTHERAPEUTIC AGENT.
  5. Samia Mahmood (M.Phil) SYNTHESIS OF 99mTc~BEVACIZUMAB AND IN VIVO STUDIES IN RATS BEARING HUMAN OVARIAN TUMOR XENOGRAFT
  6. Nazir Ullah (M.Phil) RADIOLABELING OF 99mTc ~ ETHAMBUTOL AND BIOLOGICAL EVALUATION IN ANIMAL MODELS
  7. Areefa Bajwa (M.Phil) Pre-clinical evaluation of 99mTc-p-SCN-Bn-NOTA-Bevacizumab using animal model
  8. Faiza Khan (M.Phil) TARGETING OVARIAN TUMOR USING 99mTc-p-SCN-Bn-TCMC~ BEVACIZUMAB

 

Ph.D.

  1. Gul-e-Raana (Ph.D); DEVELOPMENT OF 99mTc BASED RADIOTRACERS FOR TARGETING HEAD & NECK AND PROSTATE CANCER 
  2. Samia Mahmood (Ph.D), PRECLINICAL INVESTIGATION OF 177LU-P-SCN-BZL-NOTA-BEVACIZUMAB AS A VEGF THERANOSTICS

 

Project Coordinator  (Development Projects)

  1. Strengthening of the Department of Pharmacy University of Peshawar (from 20.10.2005 to 19.06.2007).   
  2. Strengthening and Enhancement of Academic Provisions in University of Peshawar (from 09.10.2006 to 03.05.2008)  
  3. Strengthening and Enhancement of Academic Provisions in the Faculty of Life and Environmental Sciences University of Peshawar (from 09.10.2006 to 03.05.2008)
  4. Establishment of Phytopharmaceuticals and Neutraceuticals Research Lab University of Peshawar

 

Professional Courses

  • Nuclear Reactor and Thermal Hydraulics at Pakistan Institute of Nuclear Science and Technology
  • Educational Planning and Financing at FUUAST, Islamabad.